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Abstract 
Background: Zambia continues to make strides in reducing malaria burden through the use of proven malaria 
interventions and has recently pledged to eliminate malaria by 2021. Case management services have been scaled 
up at community level with rapid diagnostic tests (RDTs) providing antigen‑based detection of falciparum malaria 
only. Key to national malaria elimination goals is the ability to identify, treat and eliminate all Plasmodium species. This 
study sought to determine the distribution of non‑falciparum malaria and assess the performance of diagnostic tests 
for Plasmodium falciparum in Western and Southern Provinces of Zambia, two provinces planned for early malaria 
elimination.
Methods: A sub‑set of individuals’ data and samples from a cross‑sectional household survey, conducted during 
peak malaria transmission season in April and May 2017, was used. The survey collected socio‑demographic informa‑
tion on household members and coverage of malaria interventions. Malaria testing was done on respondents of all 
ages using blood smears and RDTs while dried blood spots were collected on filter papers for analysis using photo‑
induced electron transfer polymerase chain reaction (PET‑PCR). Slides were stained using Giemsa stain and examined 
by microscopy for malaria parasites.
Results: From the 1567 individuals included, the overall prevalence of malaria was 19.4% (CI 17.5–21.4) by PCR, 19.3% 
(CI 17.4–21.4) by RDT and 12.9% (CI 11.3–14.7) by microscopy. Using PET‑PCR as the gold standard, RDTs showed 
a sensitivity of 75.7% (CI 70.4–80.4) and specificity of 94.2% (CI 92.8–95.4). The positive predictive value (PPV) was 
75.9% (CI 70.7–80.6) and negative predictive value (NPV) was 94.1% (CI 92.1–95.4). In contrast, microscopy for sensi‑
tivity, specificity, PPV, and NPV values were 56.9% (CI 51.1–62.5), 97.7% (CI 96.7–98.5), 85.6% (CI 80.0–90.2), 90.4% (CI 
88.7–91.9), respectively. Non‑falciparum infections were found only in Western Province, where 11.6% of P. falciparum 
infections were co‑infections with Plasmodium ovale or Plasmodium malariae.
Conclusion: From the sub‑set of survey data analysed, non‑falciparum species are present and occurred as mixed 
infections. As expected, PET‑PCR was slightly more sensitive than both malaria RDTs and microscopy to detecting 
malaria infections.
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Background
Plasmodium falciparum is the major cause of malaria 
in Africa, while P. vivax is the most widely distributed 
species outside Africa [1], and in a few African coun-
tries, such as Ethiopia [2] and Uganda [3]. Compared 
with these two dominant species, Plasmodium malar-
iae and Plasmodium ovale are significantly rarer and to 
a large extent are under-studied. Plasmodium ovale has 
been reported to be primarily distributed throughout 
sub-Saharan Africa [4]. Plasmodium malariae is found 
in tropical Africa where co-infections are sometimes 
encountered with P. falciparum [5].
Malaria remains a major public health problem in 
91 countries worldwide, despite being preventable and 
treatable. It was linked to 216 million cases and 445,000 
deaths in 2016, of which 90% were in sub-Saharan 
Africa [6]. Zambia has recorded a drop in malaria inci-
dence from 407 cases per 1000 population in 2014 to 
335 cases per 1000 population in 2015 [7] and it contin-
ues to make strides in reducing malaria cases through 
the use of proven and effective malaria interventions. It 
recently pledged to eliminate malaria altogether, through 
sustained universal coverage of vector control interven-
tions, which include indoor residual spraying (IRS), dis-
tribution of long-lasting insecticide-treated nets (LLINs) 
and larval source management (LSM). Other important 
strategies include case management, health promotion, 
surveillance, and research [8]. Case management ser-
vices are increasingly occurring at community level with 
standard rapid diagnostic tests (RDTs) providing antigen-
based detection of falciparum malaria only and treatment 
with artemisinin-based combination therapy (ACT) for 
uncomplicated malaria coupled with injectable artesu-
nate for severe cases. In addition, mass drug administra-
tion (MDA) has been included as an potential accelerator 
of the malaria elimination process [8].
Prompt and accurate case management of malaria 
infections is dependent on the performance of diag-
nostic tools. Readily available diagnostic tools include 
light microscopy of blood smears, RDTs, and molecular 
approaches such as polymerase chain reaction (PCR) and 
loop-mediated isothermal amplification (LAMP) [9, 10], 
although PCR is mostly used for research and not routine 
clinical diagnosis. Expert malaria microscopy remains an 
ideal diagnostic for malaria but due to a number of fac-
tors it cannot be used in all health facilities, hence the use 
of RDTs. RDTs are immunochromatographic tests that 
detect one or more of a range of antigens, namely histi-
dine-rich protein 2 (HRP2), Plasmodium lactate dehy-
drogenase (pLDH) and aldolase [11]. Aldolase and pLDH 
are enzymes in the glycolytic pathway, while HRP2 is a 
water-soluble protein that is produced by asexual tropho-
zoites and young gametocytes [12]. As HRP2 is produced 
exclusively during the asexual stages of the life cycle of P. 
falciparum, RDTs based on HRP2 detection are specific 
for P. falciparum [13], and are the only RDTs used in gov-
ernment health facilities in Zambia. RDTs are easy to use, 
do not require specialized training, can be performed in 
a clinic, health centre and hospital in the absence of elec-
tricity, and give results rapidly [14]. For these reasons, 
they have been widely adopted even at the lowest level in 
service delivery, the community level [15].
As with any diagnostic, there are limits to their util-
ity and in some settings have shown poor sensitivity 
and specificity. For example, in a holo-endemic area of 
northern Tanzania, the sensitivity of the ParaHIT test 
was found to be 10.7% [16], while the sensitivity of the 
SD-Bioline test assessed in South Kivu Province of the 
Democratic Republic of the Congo was found to be 
82.1% with a specificity of 92.0%, using microscopy as the 
standard [17]. The World Health Organization (WHO) 
recommended a threshold for sensitivity of > 95% and a 
threshold for specificity of > 90 [18].
As a country moves toward malaria elimination, it is 
crucial to ensure that all malaria cases irrespective of the 
infecting species are diagnosed and treated promptly. In 
Zambia, the distribution of Plasmodium species is not 
well defined. Despite this, HRP2-based RDTs are used for 
diagnosis in all facilities where microscopy is not avail-
able. This decision was based on information suggest-
ing that 98% of malaria in Zambia was P. falciparum, 2% 
were P. malariae, while P. vivax is a rare infection [19], 
which may not have changed over the years. For example, 
a cross-sectional study conducted in high transmission 
areas in Eastern and Luapula Provinces revealed approxi-
mately 10.6% of all P. falciparum infections were co-
infections with one or more other Plasmodium species. 
It is possible that in low transmission settings, the species 
distribution is different again, as species characterised 
by chronic infections (P. malariae) or dormant lifecycle 
stages (P. vivax and P. ovale) may constitute an increasing 
proportion of infections because of the chronic nature 
of P. malariae and the presence of the hypnozoite stages 
P. ovale and P. vivax [20]. These non-falciparum species 
potentially require additional interventions such as an 
anti-hypnozoite drug, e.g., primaquine.
Methods
Study design
A group of individuals were enrolled in across-sectional 
household survey conducted during peak malaria trans-
mission season in April and May 2017, as part of ongo-
ing efforts by the Zambia Ministry of Health, the PATH 
Malaria Control and Elimination Partnership in Africa 
(MACEPA) and other partners to evaluate malaria elimi-
nation efforts across Southern and Western Provinces.
Page 3 of 9Sitali et al. Malar J          (2019) 18:130 
The survey collected socio-demographic information 
on household members, coverage of malaria interven-
tions, and additional social and behavioural information 
related to use of malaria interventions. As well as testing 
for malaria in the field with an RDT (SD Bioline malaria 
Ag pf, Standard Diagnostics Inc., Republic of Korea), a 
thick blood smear and a dried blood spot (DBS) was col-
lected for analysis at the National Malaria Elimination 
Centre (NMEC) laboratory.
The sampling methods for each province were dif-
ferent due to historical studies and enumeration in 
the two provinces. In Southern Province, there was a 
pre-existing sampling frame used during a previously 
implemented MDA trial. In the trial sampling from the 
10 districts along Lake Kariba, 52 households were ran-
domly selected from each of the 60 health facility catch-
ment areas. In Western Province, where there was no 
pre-existing household sampling frame, a two-stage 
cluster sampling with clusters selected using probability 
proportional to size (a standardized method from the 
country’s Malaria Indicator Survey) was used to select 25 
households from 24 census-derived standard enumera-
tion areas [21, 22]. All consenting or assenting individu-
als above 1 month of age (n = 6977) were enrolled in the 
two surveys. Those that were severely sick, were taken to 
clinic by survey staff, but information about them would 
be collected from the household respondent and no fin-
ger stick data would be collected.
With the help of OpenEpi software (Emory University, 
Rollins School of Public Health, USA) [23], ~ 300 samples 
were calculated using the prevalence of different spe-
cies at 10.6% [34] rounding up to 11% for high transmis-
sion areas, and estimating 2% in low transmission areas, 
accuracy could be determined with 80% power and 95% 
confidence.
After excluding 41 clusters that were outliers by RDT 
prevalence, a total of 13 clusters were then randomly 
selected: 6 from Western (high RDT prevalence) and 7 
from Southern (low RDT prevalence). All individuals 
from these clusters with complete survey data, includ-
ing RDT and microscopy results, together with an iden-
tifiable DBS were selected for PCR speciation analysis 
(n = 1567), while those with insufficient blood and miss-
ing data were excluded. Due to time and cost of doing 
PCRs, all 6977 samples could not be analysed.
Study area
The two provinces, Western and Southern, cover approx-
imately 126,386  km2 (17% Western) and 85,823 km2 (11% 
Southern) of the total Zambia landmass, and are home 
to 902,974 (Western) and 1,589,926 (Southern) people, 
according to the 2010 population census. The Zambezi 
River flows through both provinces and the plains cover 
about 10% of the total area of Western Province. Tonga-
speaking people in Southern and Lozi-speaking people 
in Western are the predominant ethnic groups [24, 25]. 
A map of Zambia in Fig.  1 shows the location of these 
two provinces. Malaria transmission varies greatly across 
these two provinces, with traditionally higher transmis-
sion intensity in Southern Province along Lake Kariba 
and in areas of Western Province around the swamps and 
wetlands in Luampa, Kaoma and Nkeyema districts and 
along the Zambezi River basin [21, 22, 26]. The rest of the 
areas away from water bodies have low transmission.
Laboratory methods
Microscopy
Blood smears for microscopy were prepared in the field 
by trained biomedical scientists, air dried in a dust-free 
environment and stored in slide boxes. They were then 
transported to the NMEC where they were stained using 
3% Giemsa for 45  min. The slides were examined inde-
pendently by two experienced biomedical scientists.
DNA extraction
DNA was extracted from 6 mm (~ 13.8 µl whole blood) 
DBS punch(es)using a Qiagen DNA mini kit (Qiagen, 
Germany) and eluted in 100  µl. All RDT-positive sam-
ples were extracted alone, while RDT-negatives were 
extracted in pools of 10, and deconvoluted if positive.
PCR analysis
PET-PCR (real-time PCR technique), as previously 
described in 2013 by Lucchi et  al. [27] was used to 
amplify Plasmodium 18S ribosomal RNA (see Table  1 
materials for sequences). Briefly, 5  µl of DNA template 
(~ 0.7 µl whole blood) was amplified in a 20-µl reaction as 
follows: 95 °C for 15 min, followed by 45 cycles of 95 °C 
for 20  s and 60  °C for 40  s. Samples were analysed in 
duplicate and scored positive if both duplicates had a CT 
value < 40. The amplicon sizes were 109 bp P. falciparum, 
137 bp P. malariae, 74 bp P. ovale, and 82 bp P. vivax [28, 
29].
Statistical analysis
Demographic and laboratory data of participants’ records 
were analysed using Stata version 13 (College Station, 
Texas, USA). Fisher’s exact test for proportions was used 
to assess the association between variables and mixed 
and non-falciparum infection.
Diagnostic method performance was assessed against 
PCR as the gold standard as sensitivity [true posi-
tive (TP)/(TP + false negative (FN))], specificity [(TN)/
(TN + false positive (FP))], positive predictive value 
(PPV) [TP/(TP + FP)]and negative predictive value 
(NPV) [TN/(TN + FN)]. The results were interpreted 
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Fig. 1 Map of Zambia showing location of Southern and Western Provinces. The study area is highlighted showing the red circles indicate the exact 
locations where samples were collected in the two provinces
Table 1 Primers for species identification used for PET-PCR
Table showing forward and reverse primers for species identification used in PET-PCT assay
Primer name Sequence (5′–3′)
Original genus 18sFor GGC CTA ACA TGG CTA TGA CG
Original genus FAM 18sRev FAM‑aggcgcatagcgcctggCTG CCT TCCT TAG ATG TGG TAG CT
Falciparum For ACC CCT CGC CTG GTG TTT TT
Falciparum Rev HEX‑aggcggataccgcctggTCGG GCC CCA AAA ATA GGA A
P. vivax For GTA GCC TAA GAA GGC CGT GT
P. vivax Rev HEX‑aggcgcatagcgcctggCCT GGG G GAT GAA TAT CTC TAC AGC ACT GT
P. malariae For AAG GCA GTA ACA CCA GCA GTA 
P. malariae Rev (based on dihydrofolate reductase‑thymidylate synthase 
(DHFR‑TS) gene)
FAM‑aggcgcatagcgcctggTCC CAT GAA GTT ATA TTC CCG CTC 
P. ovale For FAM‑aggcgcatagcgcctggCCA CAG ATA AGA AGT CTC AAG TAC GAT ATT 
P. ovale Rev TTG GAG CAC TTT TGT TTG CAA 
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with 95% confidence intervals (CIs) GraphPad prism 
(GraphPad software Inc, San Diego, USA) was used to 
calculate Cohen’s Kappa agreement coefficient.
Results
Table 2 shows the general and socio-demographic char-
acteristics of the individuals included in this study. Age, 
gender, reported travel history, LLIN ownership were 
similar across both provinces, while IRS coverage was 
markedly higher in Southern (67.2%) compared to West-
ern Province (31.6%).
Malaria prevalence determined by RDT or PCR was 
broadly similar across both provinces, while microscopy 
was significantly lower. In contrast, Western Province 
had a significantly higher prevalence of malaria as com-
pared to Southern, 55 versus 4% by PCR (Fig.  2). The 
majority of all PCR-positive infections were P. falcipa-
rum mono-infections with 85.7 and 97.8% in Western 
and Southern, respectively. No mixed/co-infections were 
found in Southern Province, but 11.6% of all positives 
in Western had more than one species present (Fig.  3). 
A total of 8 non-falciparum mono-infections were also 
identified. Of these, 6 were P. ovale infections (exclusively 
from Western Province) and 2 P. malariae infections, one 
in each Province (Table 3).
Sensitivity, specificity, positive, and negative predictive 
values of diagnostic tools
RDTs had sensitivity of 75.5% [230/304 (95% CI 70.4–
80.4%)] and a specificity of 94.2% [1190/1263 (95% CI 
92.8–95.4%)], with a PPV of 75.9% [230/303 (95% CI 
70.7–80.6%)] and NPV of 1190/1264 [94.1% (95% CI 
92.1–95.4%)]. The observed agreement percentage was 
90.97%, and Cohen’s Kappa was 0.71 (CI 0.66–0.75). 
Microscopy was observed to have a sensitivity of 56.9% 
[173/304 (95% CI 51.1–62.5)], specificity of 97.7% 
[1234/1264 (95% CI 96.7–98.5)], PPV of 85.6% [173/202 
(95% CI 80.0–90.2)] and an NPV of 90.4% [1234/1365 
(95% CI 88.7–91.9)]. The observed agreement percentage 
was 89.79% and a Cohen’s Kappa of 0.63 (CI 0.57–0.68) 
(Table  4). Results from RDTs and microscopy against 
PCR showed a substantial measure of agreement.
Table  5 shows the sensitivity and specificity for RDTs 
when the standard is microscopy. The sensitivity was 
81.2% [164/202 (95% CI 75.1–86.3%)] and the specificity 
was 89.8% [1226/1365 (95% CI 88.1–91.4)], with a PPV of 
54.1% [164/303 (95% CI 48.3–59.8)] and an NPV of 97.0% 
[1226/1264 (95% CI 95.9–97.8)]. The observed agreement 
percentage was 88.70% and a Cohen’s Kappa of 0.0.59 
(CI 0.53–0.64). A moderate measure of agreement was 
observed. Cohen’s Kappa was calculated using graph pad 
online calculate [30].
Discussion
This study identified the presence of four Plasmodium 
species (P. falciparum, P. ovale, P. malariae, P. vivax) in 
Western Province and two (P. falciparum, P. malariae) 
Table 2 General and  socio-demographic characteristics 
of participants
The tables shows the general and socio-demographic characteristics of the 
participant in the two study areas
Characteristics Southern; n = 1096 Western; n = 471
n (%) CI n (%) CI
Gender
 Male 505 (46.1) 43.6–48.5 210 (44.6) 39.5–49.8
 Female 591 (53.9) 51.5–56.4 261 (55.4) 50.2–60.5
Age of children (years)
 < 5 197 (18.0) 14.2–22.5 86 (18.3) 15.6–21.2
 5–10 200 (18.3) 16.0–20.7 87 (18.5) 14.9–22.6
 11–15 178 (16.2) 13.5–19.4 69 (14.7) 10.6–20.0
 16–25 140 (12.8) 10.5–15.5 72 (15.3) 11.8–19.6
 26–40 191 (17.4) 15.1–20.0 59 (12.5) 7.4–20.3
 40–94 190 (17.7) 14.3–20.8 98 (20.8) 17.6–24.4
Travel history
 Yes 6 (0.5) 0.2–1.4 23 (4.9) 1.7–13.2
 No 1089 (99.5) 98.6–99.8 445 (95.1) 86.8–98.3
Household sprayed
 Yes 730 (67.2) 52.4–79.1 149 (31.6) 8.7–69.1
 No 357 (32.8) 20.8–47.6 322 (68.4) 30.9–91.2
ITN ownership
 Yes 673 (61.4) 38.8–80.0 269 (57.1) 29.2–81.1
 No 13 (1.2) 0.1–9.7 8 (1.7) 0.3–8.6
 Missing information 410 (37.4) 18.7–60.8 194 (41.2) 17.1–70.4
Cluster
 Average no of people/
cluster
156.5 78.5















Fig. 2 Prevalence of malaria among the participants by province
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in Southern Province. Interestingly, the diversity of para-
site species found in a province broadly correlated to the 
malaria prevalence, i.e., the higher the prevalence the 
greater the number of species found. From these data 
alone, it seems clear that non-falciparum infections are 
under-reported due to the use of P. falciparum-specific 
RDTs and challenges in achieving high quality micros-
copy [31, 32].
Overall, 97% of all malaria infections contained P. 
falciparum, of which 89% were mono-infections and 
11.6% co-infections and very few mono non-falciparum 
infections were identified (< 3% of all infections). These 
findings are in agreement with previous studies which 
reported 10.6% mixed infections and 88% P. falciparum 
[33], and are also close to 98% P. falciparum reported 
by Wolfe [34]. The findings suggest that transmission 





































Fig. 3 Prevalence of Plasmodium falciparum, mixed infection and 
mono non‑falciparum infection by PET‑PCR
Table 3 Differential species distribution by province
The majority of the infections were P. falciparum, with (222/259) 85.7% and (44/45) 97.8% in Western and Southern, respectively. There were (30/259) 11.6% (95% CI 
8.4–16.0%) mixed infections in Western, while none were observed in Southern Provinces. The combination observed in Western Province were Pf/Pv 1/259 (0.4%), Pf/
Po 26/259 (10.0%). Pf/Pm 3/259 (1.2%)
Pf: Plasmodium falciparum; Pm: P. malariae; Po: P. ovale; Pv: P. vivax
Province Western Southern Overall
n % n % n %
Pf only 222 85.7 44 97.8 266 87.5
Po only 6 2.3 6 2.0
Pm only 1 0.4 1 2.2 2 0.7
Pf and Pv 1 0.4 1 0.3
Pf and Po 26 10.0 26 8.6
Pf and Pm 3 1.2 3 1.0
Total 259 45 304
Table 4 Performance of RDTs and microscopy compared to PCR results
PPN: positive predictive value; NPV: negative predictive value
PCR Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Positive Negative
RDTs
 Positive 230 73 303 75.5% (70.4, 80.4) 94.2% (92.8, 95.4) 75.9% (70.7, 80.6) 94.1% (92.1,95.4)
 Negative 74 1190 1264
 Total 304 1263 1567
PCR Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Positive Negative
Microscopy
 Positive 173 29 202 56.9% (51.1, 62.5) 97.7% (96.7, 98.5) 85.6% (80.0, 90.2) 90.4% (88.7, 91.9)
 Negative 131 1234 1365
 Total 304 1264 1567
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that transmission of each species is occurring in the 
same geography/human population. It is well known 
that some mosquito species are capable of transmit-
ting multiple parasite species, e.g. Anopheles gambiae 
is able to transmit all Plasmodium species [35] and is 
found throughout Southern and Western Provinces. 
While the vectorial capacity for transmission is present 
in both provinces, it is unclear how much non-P. falci-
parum transmission is local and how much is imported 
through travel [35]. Considering the numbers, it is 
entirely plausible that P. malariae in Southern Province 
is maintained through importation, while there is more 
robust local non-P. falciparum transmission in West-
ern Province. No association was found between travel 
history and presence of non-falciparum infections 
however, only travel in the last month was recorded. 
Considering non-falciparum malaria infections may be 
chronic or dormant for long periods of time, it is not 
possible to determine the source of infections in this 
study. Genotyping of the parasite population may help 
dissect this relationship by defining the parasite popu-
lation diversity and relatedness of different infections.
Often the non-falciparum species are under-reported 
or not identified due to a number of factors: the use of P. 
falciparum-specific RDTs as observed in approximately 
63% of health facilities in Zambia [36] and microscopy-
related challenges, such as inadequate experience and 
training of microscopists to identify parasites other 
than P. falciparum [31, 32]. Other factors include mor-
phological changes induced by haemolysis hampering 
the identification of the species [31].
While evidence for P. vivax transmission exists [37], 
the majority of the Zambian population are expected to 
be resistant to P. vivax infections due to carrying the 
Duffy FyFy genotype [38]. It was, therefore, surprising 
to find P. vivax, albeit in only one person. There is evi-
dence of low-level P. vivax endemicity in sub-Saharan 
Africa [39, 40]. Evidence from the Malaria Atlas Project 
(MAP) shows that Zambia’s neighbours, Democratic 
Republic of Congo, Namibia, Botswana and Angola, 
have cases of P. vivax [39].
The sensitivity value was below the 95% threshold for 
both RDTs and microscopy when compared to PCR, 
while specificity was above the recommended 90%. The 
findings of RDT sensitivity of 75.5% using PCR as gold 
standard is consistent with other publications on RDT 
sensitivity e.g., 88.6% in mainland Tanzania [41], 76.5% 
in Zanzibar [42] and 75.4% in Kisumu, Kenya [43].
In this study RDTs and microscopy had a relatively 
low PPV (< 90%), meaning that many positives were not 
infected, which in turn affects malaria morbidity, preva-
lence and incidence estimates [43]. Furthermore, treat-
ment given to false positives is potentially costly and 
may lead to inaccurate perceptions of therapeutic fail-
ures [43]. A proportion of false positive individuals may 
reflect a recent resolved past infection due to HRP2 per-
sistence. Conversely, a proportion of false negatives could 
be due to the functional loss of HRP2 expression, e.g., 
through a gene deletion as has been reported in neigh-
bouring DRC [44]. Finally, the prozone effect in hyper-
parasitaemic infections could also account for some of 
the false negatives [45, 46], although in this study the cor-
relation between parasite density and false negatives was 
not assessed.
Study limitations and strengths
Results of this study should be interpreted keeping some 
limitations in mind. Firstly, there was no similar pre-
2017 analysis of species in Southern Province to indicate 
whether there was previously a higher level of mixed and 
non-falciparum species present. This makes it difficult 
to be certain if the elimination activities in the province 
are responsible for the low positivity rate. Secondly, these 
data cannot be generalized to the whole country, as this 
analysis is for two provinces, despite representing lower 
and higher transmission zones (low meaning an area with 
parasitaemia less than 5% and high meaning an area with 
parasitaemia above 15%), and the moderate transmission 
zone is not represented. Thirdly, an element of selection 
bias cannot be excluded as clusters with zero RDT preva-
lence were excluded. It is possible that the clusters may 
have had non-falciparum species leading to underestima-
tion of the species. Finally, the study used secondary data 
and the authors have little or no control of RDT results, 
which may have affected the sensitivity and specificity 
results. Four samples from participants that were RDT-
positive and PCR-negative, who were given treatment 
within 14 days, were included in the analysis. It is possi-
ble that the positive RDTs could have been due to lagging 
antigenaemia. Although on recalculation of sensitivity 
and specificity, new figures were within the same range as 
those previously calculated.




Positive 164 139 303 Se = 81.2% (75.1, 86.3), 
Sp = 89.8% (88.1, 91.4), 
Ppv = 54.1% (48.3, 
59.8), Npv = 97.0% 
(95.9, 97.8)
Negative 38 1226 1264
Total 202 1365 1567
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Conclusion
There is a concern that other species could continue to 
drive transmission but remain undetected, as the RDTs 
currently used in Zambia detect only P. falciparum. 
While this study confirms that P. falciparum dominates, 
a not-insignificant 9.9% of these infections were mixed 
with another species. Encouragingly, where malaria is 
closest to elimination (i.e., in Southern Province), non-
falciparum infections identified in this study were mini-
mal (1 case). This may suggest that interventions that 
reduce P. falciparum transmission also impact non-fal-
ciparum species. It is important to expand surveillance 
activities to monitor non-falciparum infections and 
ensure this remains the case.
From the finding, recommendation made include: the 
national malaria programme consider increasing capac-
ity to diagnose and detect non-falciparum species. This 
can be done through strengthening diagnosis quality 
assurance, increase access to functional microscopy, and 
provide refresher training in malaria microscopy for all 
laboratory staff, and in addition, introduce Pan RDTs 
(RDTs able to diagnose P. falciparum and non-falciparum 
species).
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